Funding
1 min read
Deep Intelligent Pharma raised nearly 50 million USD in Series D financing to scale its AI-native cl...
The AMW Read
Updates the player map for the AI-native clinical trial sub-segment within Vertical AI—Healthcare/Bio with a significant Series D round.
NoveltySignificance
Healthcare & Bio · Player Map
Deep Intelligent Pharma raised nearly 50 million USD in Series D financing to scale its AI-native clinical trial engine. Utilizing a bionic ecosystem of 10,000 atomic agents, the platform achieves 99.9 percent accuracy and 90 percent time savings. This shift to decision-making infrastructure directly targets the 40 percent failure rate in trials. The industry is adopting a simulate first, execute later model to de-risk high-value drug assets. 🚀 #AI #Biotech #Financing #Pharma
